A

nyone who likes to post information about drugs on social media might want to read this: The Danish Medicines Agency is investigating whether an Amgen (AMGN) employee in Denmark violated advertising laws by sharing and liking a U.S. press release about the Kyprolis medication on LinkedIn. If the law was broken, the company may have to pay a penalty and the employee could face up to four months in jail.

An agency spokesman declined to provide further details, but explained that advertising prescription medicines to the general public is prohibited. Under Danish law, the general public is defined as anyone who is not a doctor, dentist, veterinarian, pharmacist, nurse, midwife, bioanalyst, clinical dietitian, radiographer, or student in one of these fields.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.